Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
about
Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathyElectroacupuncture counteracts the development of thermal hyperalgesia and the alteration of nerve growth factor and sensory neuromodulators induced by streptozotocin in adult ratsPainful Diabetic Neuropathy: Prevention or Suppression?TRPV1: A Potential Drug Target for Treating Various Diseases.Differential vulnerabilities of urethral afferents in diabetes and discovery of a novel urethra-to-urethra reflexHerbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.Contribution of primary afferent channels to neuropathic pain.Alpha-lipoic Acid suppresses P2X receptor activities and visceral hypersensitivity to colorectal distention in diabetic rats.Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male micePropofol restores transient receptor potential vanilloid receptor subtype-1 sensitivity via activation of transient receptor potential ankyrin receptor subtype-1 in sensory neurons.Transient receptor potential channels: targeting pain at the source.Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediatorsMechanisms underlying purinergic P2X3 receptor-mediated mechanical allodynia induced in diabetic ratsFSP-1 Impairs the Function of Endothelium Leading to Failure of Arteriovenous Grafts in Diabetic MiceModulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathySystematic Review and Meta-Analysis on Incidence of Altered Sensation of Mandibular Implant SurgeryPreventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in ratsEvaluating dermal myelinated nerve fibers in skin biopsy.Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy.P2X₃ and TRPV1 functionally interact and mediate sensitization of trigeminal sensory neurons.Increased nerve growth factor signaling in sensory neurons of early diabetic rats is corrected by electroacupuncture.Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice.Modulation of transient receptor potential Vanilloid 4-mediated membrane currents and synaptic transmission by protein kinase C.TRPV1 Antagonists and Chronic Pain: Beyond Thermal PerceptionPathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Alterations in the neural circuits from peripheral afferents to the spinal cord: possible implications for diabetic polyneuropathy in streptozotocin-induced type 1 diabetic rats.A Role for Insulin in Diabetic Neuropathy.Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel.Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.Role of oxidative stress and Ca²⁺ signaling on molecular pathways of neuropathic pain in diabetes: focus on TRP channels.Transient receptor potential channels as targets for phytochemicals.Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.TRPs and pain.TRPing on the pore phenomenon: what do we know about transient receptor potential ion channel-related pore dilation up to now?Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists.Real-Time Translocation and Function of PKCβII Isoform in Response to Nociceptive Signaling via the TRPV1 Pain Receptor.Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies.Functional interactions between NMDA receptors and TRPV1 in trigeminal sensory neurons mediate mechanical hyperalgesia in the rat masseter muscle.
P2860
Q28306961-6743C189-4D59-4A18-A210-FFC16F811670Q28565699-762FAD60-1060-48D2-8FD7-CA0ED90FBAB5Q30352607-8C3B4AA0-16F9-4EAB-BF98-4A446615AA89Q30434994-59B1DC64-51C6-48E7-A706-781D6EA1308AQ33589098-917A410D-D40D-4AD0-816E-AA5F4CDBA4C3Q33770708-9A08D25C-1427-4088-A917-9FC7B8730816Q33810382-8F2DF052-C7EA-4805-9B02-0ED2A072CF60Q33849181-B73A7C6F-D21A-4124-928C-562693164EB7Q33954651-CDFC1B00-F728-4548-B75A-904C973A4AEFQ34387316-220AA412-703C-46EF-8D55-484A345A0399Q34899576-AB66CD52-756A-43C5-A327-8E79C2677CDBQ34912798-6C3FE6D3-9041-49D2-8450-09251BD1062CQ35168721-D905B682-F2AF-4DF0-868C-D3433E932819Q35200553-AC61686A-4121-4AD6-82F0-9606E1D12A41Q35603308-1DF47729-0109-4870-922B-0C8109343F33Q35911991-FEB39DF5-C971-48DB-A057-FAA2DAA42B83Q35996005-4CDFE67F-C3C7-4654-AC77-141AC7D584C4Q36254642-F2F0AD6F-ED77-4E07-B362-8FD4ABDB8F6CQ36484556-767A6FE8-D8D6-4731-ADF5-765810DBA24EQ36674750-735F0235-4D53-438D-9F02-CACD135C9B66Q36692631-2FCFD935-CFE8-4615-A9FD-DC58DA0F6088Q36844962-F34B4B87-4045-4ECF-BC61-59E10FBEFD9EQ37030606-7AB36059-FB69-427D-BA5A-586DD0B6FEB1Q37116100-F9AC7C2E-464F-419C-9CF8-081A95A020CDQ37148698-C1AB5B98-BB38-4781-851B-B9D6E1EB6587Q37399781-540E441C-C9D7-4294-8D35-48A9D3D9BBDBQ37526316-8B242C08-FED0-443E-90A9-314329CF702BQ37528638-3DBFE089-6FE5-44DC-A20F-1A4D25B512FFQ37683369-399BEBD3-DAA1-4DBF-8754-60BE1DC49D30Q37988158-5CFFC01A-5809-48DE-AE8A-63137743DB36Q38030805-8D573C92-7172-48C8-A63F-64C56A8AC11CQ38220010-D92A3FE2-EACC-47BC-A54D-74178E1D28FFQ38571878-34B9FCCB-53F1-41E5-BAE9-CD6EEA3C8739Q38587736-8A9AF269-CCE1-461E-A8E9-1DC0A4629FE5Q38686108-0E4181C7-817B-4826-8C08-5564534D251CQ39038882-36ADEE17-FED4-430F-ACD5-0DB39394E853Q40784189-98992F0B-4AAE-4381-B479-46E43037EBE2Q41789029-F2903EFA-4042-46FA-A2E0-29BDA97B5E4EQ41815253-E02DB875-849D-43EC-8F64-FBEEA6277192Q41880953-63EC6150-8A64-4346-9C95-A71AB3FFB720
P2860
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@ast
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@en
type
label
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@ast
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@en
prefLabel
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@ast
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@en
P2093
P2860
P356
P1433
P1476
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.
@en
P2093
Louis S Premkumar
Mary E Pauza
Reddy M Pabbidi
Romesh Khardori
Shuang-Quan Yu
Siying Peng
P2860
P2888
P356
10.1186/1744-8069-4-9
P577
2008-03-01T00:00:00Z
P5875
P6179
1036393935